Holder plans sale of 24,001 ALLO shares

A holder of ALLO common stock has filed a Rule 144 notice to sell 24,001 shares through Morgan Stanley Smith Barney LLC on or about 02/02/2026 on NASDAQ.

Rhea-AI Filing Summary

A holder of ALLO common stock has filed a Rule 144 notice to sell 24,001 shares through Morgan Stanley Smith Barney LLC on or about 02/02/2026 on NASDAQ. The aggregate market value of the planned sale is listed as $42,188.96, with issuer shares outstanding of 224,730,144.

The shares were acquired as restricted stock vesting under a registered compensation plan from the issuer on 01/31/2026, in a non-cash transaction classified as compensation. The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Rule 144 filing disclose for ALLO?

The filing discloses a planned sale of 24,001 ALLO common shares under Rule 144, with an aggregate market value of $42,188.96, to be sold on NASDAQ around 02/02/2026 through Morgan Stanley Smith Barney LLC.

How many ALLO shares are planned to be sold and at what value?

The holder plans to sell 24,001 common shares of ALLO. The filing lists an aggregate market value of $42,188.96 for these shares, giving investors a sense of the transaction’s disclosed dollar size at the time of the notice.

How were the ALLO shares being sold under Rule 144 acquired?

The shares were acquired as restricted stock vesting on 01/31/2026 under a registered compensation plan from the issuer. The consideration is described as compensation, indicating the shares were granted rather than purchased for cash.

What does the filer represent about ALLO’s non-public information?

The person for whose account the securities will be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the certification language included in the notice.

How many ALLO shares are reported as outstanding in the filing?

The notice reports 224,730,144 shares of the issuer’s common stock as outstanding. This figure provides context for the size of the planned 24,001-share sale relative to the issuer’s total reported common shares.

Which broker will handle the planned ALLO share sale under Rule 144?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker that will handle the planned sale of the 24,001 ALLO common shares on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 05:16 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001491874
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALLOGENE THERAPEUTICS, INC.
SEC File Number	001-38693
Address of Issuer	210 East Grand Avenue South San Francisco CALIFORNIA 94080
Phone	(650) 457-2700
Name of Person for Whose Account the Securities are To Be Sold	GEOFFREY M PARKER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24001	42188.96	224730144	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted stock vesting under a registered plan	Issuer			24001	01/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Geoffrey Parker
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)